Canada, Japan and New Zealand reported that the glyphosate was unlikely to pose any carcinogenic risk to humans. California put glyphosate on its list of unsafe chemicals. Since the publishing, IARC claimed it has suffered unprecedented large-scale attacks on its reputation from the agro-chemical industry. Industry reactions The American Chemistry Council (ACC), the trade group for U.S. chemical companies, declared that IARC evaluates how hazardous a substance is based on whether the substance could "cause cancer in humans under any circumstances, including at exposure levels beyond what is typical." U.S. Congressional reactions In early 2016, members of the scientific panel that reviewed glyphosate in 2015 were issued legal requests in the U.S. related to their work. In April 2016, internal IARC officials told its experts to not release documents or comply with the legal requests related to its review of glyphosate. In the fall of 2016, the U.S. House Committee on Oversight and Government Reform held a briefing to ask officials from the National Institutes of Health (NIH) about NIH's grant funding to the IARC. The NIH grant database showed that it has given the IARC over $1.2 million in 2016. Jason Chaffetz (Republican) asked the NIH to give his committee details of its standards for awarding grants and vetting grant nominees. Additionally, Congressman Robert Aderholt (Republican), chairman of the House Appropriations Subcommittee on Agriculture, wrote a letter in June 2016 to the head of the NIH questioning the funding of IARC. Republican congressman Jason Chaffetz argued that the IARC is too prone to conclude that substances are carcinogenic. However, IARC respond that the Working Groups methods are "widely respected for their scientific rigor, standardized and transparent process and for freedom from conflicts of interest." Director of IARC Chris Wild further added that the IARC only chooses substances to evaluate from which there already exists a body of scientific literature that says there is a carcinogenic risk to humans. Wild said that because IARC does not select substances at random, it has a low rate of determining a substance as not being cancer-causing. Criticism of monographs methodology On 26 October 2015, a Working Group of 22 experts from 10 countries evaluated the carcinogenicity of the consumption of red meat and processed meat and classified the consumption of red meat as "probably carcinogenic to humans (Group 2A)", mainly related to colorectal cancer, and to pancreatic and prostate cancer. It also evaluated